Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Mar-24 4:15 PM View:  | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 765 | $7.70 | $5,890.50 | (< 1%) 530.88K to 530.11K | |
| 29-Mar-24 4:15 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 348 | $7.70 | $2,679.60 | (< 1%) 341.85K to 341.5K | |
| 29-Mar-24 4:15 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 348 | $7.70 | $2,679.60 | (< 1%) 327.74K to 327.39K | |
| 29-Mar-24 4:15 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 298 | $7.70 | $2,294.60 | (< 1%) 514.98K to 514.68K | |
| 31-Jan-24 4:08 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 3,178 | $9.64 | $30,635.90 | (< 1%) 534.06K to 530.88K | |
| 31-Jan-24 4:11 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 2,005 | $9.64 | $19,328.20 | (< 1%) 343.85K to 341.85K | |
| 31-Jan-24 4:05 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 1,929 | $9.64 | $18,595.60 | (< 1%) 329.67K to 327.74K | |
| 31-Jan-24 4:14 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 1,651 | $9.64 | $15,915.60 | (< 1%) 516.63K to 514.98K | |
| 18-Jan-24 4:16 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 200,000 | -- | -- | 139% 143.85K to 343.85K | |
| 18-Jan-24 4:10 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 200,000 | -- | -- | 154% 129.67K to 329.67K | |
| 18-Jan-24 4:25 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 200,000 | -- | -- | 63% 316.63K to 516.63K | |
| 18-Jan-24 4:19 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 762,360 | -- | -- | 56% 1.36M to 2.13M | |
| 18-Jan-24 4:13 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 300,000 | -- | -- | 128% 234.06K to 534.06K | |
| 29-Dec-23 4:14 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 294 | $11.51 | $3,383.94 | (< 1%) 129.96K to 129.67K | |
| 29-Dec-23 4:26 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 244 | $11.51 | $2,808.44 | (< 1%) 316.87K to 316.63K | |
| 29-Dec-23 4:17 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 977 | $11.51 | $11,245.30 | (< 1%) 235.03K to 234.06K | |
| 29-Dec-23 4:22 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 294 | $11.51 | $3,383.94 | (< 1%) 144.15K to 143.85K | |
| 01-Nov-23 4:14 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 30-Oct-23 | Sale | 3,451 | $6.03 | $20,809.50 | (1%) 238.48K to 235.03K | |
| 01-Nov-23 4:18 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 30-Oct-23 | Sale | 1,697 | $6.03 | $10,232.90 | (1%) 145.84K to 144.15K | |
| 01-Nov-23 4:07 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 30-Oct-23 | Sale | 1,632 | $6.03 | $9,840.96 | (1%) 131.59K to 129.96K | |
| 01-Nov-23 4:21 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 30-Oct-23 | Sale | 1,354 | $6.03 | $8,164.62 | (< 1%) 318.23K to 316.87K | |
| 29-Sep-23 4:10 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Sep-23 | Sale | 294 | $8.38 | $2,463.72 | (< 1%) 131.89K to 131.59K | |
| 29-Sep-23 4:32 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Sep-23 | Sale | 244 | $8.38 | $2,044.72 | (< 1%) 318.47K to 318.23K | |
| 29-Sep-23 4:52 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Sep-23 | Sale | 648 | $8.38 | $5,430.24 | (< 1%) 239.13K to 238.48K | |
| 29-Sep-23 4:22 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Sep-23 | Sale | 294 | $8.38 | $2,463.72 | (< 1%) 146.14K to 145.84K | |
| 31-Jul-23 4:48 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 28-Jul-23 | Sale | 2,683 | $11.80 | $31,659.40 | (1%) 240.59K to 237.9K | |
| 31-Jul-23 4:50 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 28-Jul-23 | Sale | 1,693 | $11.80 | $19,977.40 | (1%) 147.83K to 146.14K | |
| 31-Jul-23 4:46 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 28-Jul-23 | Sale | 1,628 | $11.80 | $19,210.40 | (1%) 133.51K to 131.89K | |
| 31-Jul-23 4:52 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 28-Jul-23 | Sale | 1,352 | $11.80 | $15,953.60 | (< 1%) 318.16K to 316.81K | |
| 29-Sep-23 4:52 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 30-Jun-23 | Grant | 1,228 | $10.68 | $13,115.00 | < 1% 240.59K to 241.81K | |
| 29-Sep-23 5:27 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 30-Jun-23 | Grant | 1,662 | $10.68 | $17,750.20 | < 1% 1.36M to 1.36M | |
| 29-Sep-23 4:32 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 30-Jun-23 | Grant | 1,662 | $10.68 | $17,750.20 | < 1% 318.16K to 319.82K | |
| 28-Jun-23 5:08 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Jun-23 | Sale | 294 | $12.12 | $3,563.28 | (< 1%) 148.12K to 147.83K | |
| 28-Jun-23 5:02 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Jun-23 | Sale | 294 | $12.12 | $3,563.28 | (< 1%) 133.81K to 133.51K | |
| 28-Jun-23 5:12 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Jun-23 | Sale | 244 | $12.12 | $2,957.28 | (< 1%) 318.4K to 318.16K | |
| 28-Jun-23 5:06 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Jun-23 | Sale | 647 | $12.12 | $7,841.64 | (< 1%) 241.23K to 240.59K | |
| 01-Jun-23 6:24 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 30-May-23 | Grant | 161,818 | -- | -- | 103% 156.59K to 318.4K | |
| 26-May-23 4:14 PM View: | Shawver Laura Director | Relay Therapeutics, Inc. (RLAY) | 24-May-23 | Gift | 12,099 | -- | -- | (23%) 52.1K to 40.0K | |
| 01-May-23 4:26 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 28-Apr-23 | Sale | 863 | $11.16 | $9,631.08 | (< 1%) 135.75K to 134.88K | |
| 01-May-23 4:33 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 28-Apr-23 | Sale | 739 | $11.16 | $8,247.24 | (< 1%) 158.24K to 157.5K | |
| 01-May-23 4:29 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 28-Apr-23 | Sale | 1,383 | $11.16 | $15,434.30 | (< 1%) 244.08K to 242.7K | |
| 01-May-23 4:31 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 28-Apr-23 | Sale | 863 | $11.16 | $9,631.08 | (< 1%) 150.13K to 149.27K | |
| 28-Mar-23 4:52 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Mar-23 | Sale | 297 | $15.36 | $4,561.92 | (< 1%) 158.54K to 158.24K | |
| 28-Mar-23 4:50 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Mar-23 | Sale | 347 | $15.36 | $5,329.92 | (< 1%) 150.48K to 150.13K | |
| 28-Mar-23 4:47 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Mar-23 | Sale | 347 | $15.36 | $5,329.92 | (< 1%) 136.09K to 135.75K | |
| 28-Mar-23 4:49 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Mar-23 | Sale | 763 | $15.36 | $11,719.70 | (< 1%) 244.85K to 244.08K | |
| 09-Feb-23 5:09 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 09-Feb-23 | Planned Option Sale | 14,000 | $20.55 | $287,700.00 | (1%) 1.38M to 1.36M | |
| 09-Feb-23 5:09 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 09-Feb-23 | Option Exercise | 14,000 | $5.04 | $70,560.00 | 1% 1.36M to 1.38M | |
| 09-Feb-23 5:09 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 08-Feb-23 | Planned Option Sale | 14,000 | $20.98 | $293,720.00 | (1%) 1.38M to 1.36M | |
| 09-Feb-23 5:09 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 08-Feb-23 | Option Exercise | 14,000 | $5.04 | $70,560.00 | 1% 1.36M to 1.38M |
